250 likes | 379 Vues
This document addresses key challenges in managing hemophilia programs, focusing on the comparison between prophylaxis and on-demand therapy. It explores the degrees of hemophilia, the implications of joint outcome studies, and continuous factor replacement therapy protocols. The SPINART study's design and findings are discussed, as well as strategies to improve patient adherence to treatment per the WHO definition. The summary highlights advancements in longer-acting factor replacement therapies and tools like VERITAS-Pro for better patient outcomes.
E N D